Ｌ−ドーパ、ドーパデカルボキシラーゼ阻害剤、カテコール−Ｏ−メチルトランスフェラーゼ阻害剤、およびそれらのための組成物の継続的投与

摘要

Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods.